CervoMed to Participate in Upcoming Investor Conferences
(NASDAQ:CRVO) BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announ...
11 days ago